A new statewide research initiative is underway to evaluate an experimental blood test that could change the future of cancer screening.

Steatotic liver disease often progresses asymptomatically, with the risk of advancing to cirrhosis and liver cancer. Early detection of advanced liver disease through screening presents an opportunity ...

Endocrine Society experts encouraged more widespread screening for a common hormonal cause of high blood pressure known as ...

St. Luke’s offers a $49 three-part vascular screening test that looks for signs of aortic aneurysms, stroke and peripheral artery disease — the three most serious, non-cardiac-related vascular ...

Cardiologist Dr Vashisth emphasises the importance of comprehensive screenings, other than ECG, to find heart diseases, as ...

The SmartVascular Dx test stands at the forefront of preventative healthcare, enabling the early detection of vascular inflammation before clinical symptoms arise. This is especially crucial in ...

Multicancer Early Detection Tests Multicancer early detection (MCED) screening tests, also called “liquid biopsy” tests, are designed to detect minute quantities of circulating tumor DNA and ...

“The SmartVascular Dx test is not just a diagnostic tool; it’s a powerful resource for clinicians aimed at redefining our response to vascular risk.

Vascular disease continues to be a leading cause of morbidity and mortality worldwide. The SVDx test leverages state-of-the-art technology to provide comprehensive insights into a patient’s ...

HPV tests, which are similarly effective at screening for cancer or precancer, look for the presence of HPV genotypes that are likely to cause cancer. The company’s “Teal Wand” is also an HPV test ...